Complete, long-term remission of refractory idiopathic cold haemagglutinin disease after Mabthera

被引：12

作者：

Gharib, M ^{[1
]}

Poynton, C ^{[1
]}

机构：

[1] Univ Wales Coll Med, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 01期

关键词：

Mabthera; anti CD20; monoclonal; cold haemagglutinin disease; haemolysis;

D O I：

10.1046/j.1365-2141.2002.3406_2.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：248 / 249

页数：2

共 6 条

[1] Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haematolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma. [J].

Bauduer, F .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) :1085-1086

[2] No response to cladribine in five patients with chronic cold agglutinin disease [J].

Berentsen, S ;

Tjonnfjord, GE ;

Shammas, FV ;

Bergheim, J ;

Hammerstrom, J ;

Langholm, R ;

Ulvestad, E .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (01) :88-90

[3] Remission of severe cold agglutinin disease after Rituximab therapy [J].

Layios, N ;

Van den Neste, E ;

Jost, E ;

Deneys, V ;

Scheiff, JM ;

Ferrant, A .

LEUKEMIA, 2001, 15 (01) :187-188

[4] Rituxan in the treatment of cold agglutinin disease [J].

Lee, EJ ;

Kueck, B .

BLOOD, 1998, 92 (09) :3490-3491

[5] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[6]

ROSSE W, 1997, HEMATOLOGY 1997, P92

← 1 →